Multi-Cancer DNA Blood Test (SPOT-MAS)
Early Detection for Higher Chances of Recovery
The Rising Challenge of New Cancer Cases
In Thailand, an average of 381 people are diagnosed with cancer every day*. Cancer remains a leading cause of death worldwide, making early screening more critical than ever.
*2022 data from the National Health Security Office (NHSO), https://www.nhso.go.th/news/3893
Detect Early, Live Longer
Detecting cancer in its earliest stages can increase survival rates to 90-95%. However, over 70% of patients only discover cancer in its late stages, when treatment becomes more complex and the financial burden on families increases. The WHO predicts cancer-related deaths will rise by 45% by 2030.
Finding cancer early allows for immediate treatment, higher survival rates, and significantly lower medical costs.
SPOT-MAS: Searching for Cancer DNA in the Blood
SPOT-MAS is a Multi-Cancer Early Detection (MCED) technology. It scans for Circulating Tumor DNA (ctDNA)—fragments of DNA released by cancer cells into the bloodstream. Using advanced Next-Generation Sequencing (NGS), this test can detect multiple types of cancer simultaneously in asymptomatic individuals with just a single blood draw.
Screen for 5 Major Cancers at Once
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
Advantages of the SPOT-MAS Test
- Simple & Minimally Invasive: Requires only one blood sample to screen for multiple cancers.
- Non-Surgical: No need for invasive procedures like tissue biopsies during the screening phase.
- High Accuracy: Features 95.9% specificity and 73.9% sensitivity*.
- Fast Results: Receive your report within 14 working days.
Who Should Get Tested?
- Aged 40+: The WHO recommended age for regular cancer screening due to increased risk.
- Lifestyle Risks: Regular smokers or heavy alcohol consumers.
- Environmental Risks: People living in areas with high PM 2.5 levels.
- Family History: Those with relatives who have had cancer (genetic risk).
- Proactive Health Seekers: Anyone aged 18+ who wishes to establish an early baseline for cancer screening.
In addition to DNA testing, it is important to maintain regular check-ups, such as mammograms and pap smears, as part of an annual health program tailored to your age and specific risks.